Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,307 | 2,741 | 78 | 57 | N/A |
| Receivables | N/A | 32 | 35 | 190 | N/A |
| Inventories | N/A | N/A | N/A | 91 | N/A |
| Other current assets | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $1,424 | $2,837 | $170 | $393 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 344 | 26 | 24 | 29 | N/A |
| Intangibles | 0 | 667 | 1,109 | 1,233 | 0 |
| Other Non-Current Assets | 1,666 | 30 | 911 | 128 | 0 |
| TOTAL | $2,010 | $723 | $2,045 | $1,390 | $N/A |
| Total Assets | $3,434 | $3,559 | $2,215 | $1,783 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,221 | 1,077 | 1,451 | 542 | 0 |
| Accrued Expenses | 333 | 413 | 924 | 341 | N/A |
| TOTAL | $1,876 | $1,523 | $2,920 | $1,327 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33 | 33 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 568 | 0 | 10,322 | 4,675 | 0 |
| TOTAL | $568 | $N/A | $10,425 | $4,675 | $N/A |
| Total Liabilities | $2,444 | $1,523 | $13,345 | $6,002 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 769 | 567 | N/A | N/A | N/A |
| Retained earnings | -56,188 | -48,563 | -35,520 | -27,728 | N/A |
| TOTAL | $990 | $2,036 | $-11,131 | $-4,219 | $N/A |
| Total Liabilities And Equity | $3,434 | $3,559 | $2,215 | $1,783 | $0 |